Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures

Icro Meattini, Philip Poortmans, L. Marrazzo, Isacco Desideri, Étienne Brain, Marije E. Hamaker, Matteo Lambertini, Guido Miccinesi, Nicola S. Russell, Calogero Saieva, Vratislav Strnad, Luca Visani, Orit Kaidar‐Person, Lorenzo Livi

2020Journal of Geriatric Oncology79 citationsDOI

Topics & Concepts

MedicineBreast cancerRadiation therapyQuality of life (healthcare)Randomized controlled trialPopulationLife expectancyBreast-conserving surgeryCancerEndocrine systemInternal medicineOncologyMastectomyEnvironmental healthHormoneNursingBreast Cancer Treatment StudiesBreast Implant and ReconstructionCancer Treatment and Pharmacology

Exclusive endocrine therapy or partial breast irradiation for women aged ≥70 years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures

Topics & Concepts

Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures